Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular CarcinomaCancer Research CommunicationsJune 29, 202310.1158/2767-9764.crc-23-0072Cited by 32SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis